daunorubicin has been researched along with mkt 077 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, JM; Gu, M; Hartley, JA; Hochhauser, D; Lo, S; Schapira, AH; Taanman, JW; Tolner, B | 1 |
1 other study(ies) available for daunorubicin and mkt 077
Article | Year |
---|---|
Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Blotting, Southern; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Daunorubicin; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Mitochondrial; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Immunoblotting; Inhibitory Concentration 50; Intracellular Membranes; Membrane Potentials; Pyridines; Thiazoles; Tumor Suppressor Protein p53 | 2005 |